HMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia
| dc.contributor.author | Roug, Anne S. | |
| dc.contributor.author | Larsen, Hanne O. | |
| dc.contributor.author | Nederby, Line | |
| dc.contributor.author | Just, Tom | |
| dc.contributor.author | Brown, Gordon | |
| dc.contributor.author | Nyvold, Charlotte G. | |
| dc.contributor.author | Ommen, Hans B. | |
| dc.contributor.author | Hokland, Peter | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2018-10-17T23:06:33Z | |
| dc.date.available | 2018-10-17T23:06:33Z | |
| dc.date.issued | 2014-01-01 | |
| dc.description | The work was supported by grants to PH from The Danish Cancer Society, The Danish MRC, The John and Birthe Meyer Foundation, and the Karen Elise Jensen Foundation. GB has received funding from The Wellcome Trust. We thank our patients for contributing samples, and for continuous input during these efforts. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 523603 | |
| dc.identifier | 139691843 | |
| dc.identifier | f70e9dae-8db3-4b36-b9a0-44570771c78c | |
| dc.identifier | 84891624172 | |
| dc.identifier | 24152218 | |
| dc.identifier.citation | Roug, A S, Larsen, H O, Nederby, L, Just, T, Brown, G, Nyvold, C G, Ommen, H B & Hokland, P 2014, 'HMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia', British Journal of Haematology, vol. 164, no. 2, pp. 212-222. https://doi.org/10.1111/bjh.12614 | en |
| dc.identifier.doi | 10.1111/bjh.12614 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 0007-1048 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11285 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=84891624172&partnerID=8YFLogxK | en |
| dc.identifier.vol | 164 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | British Journal of Haematology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Acute myeloid leukaemia | en |
| dc.subject | Flow cytometry | en |
| dc.subject | Leukaemia-associated immunophenotype | en |
| dc.subject | Minimal residual disease | en |
| dc.subject | Quantitative polymerase chain reaction | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Hematology | en |
| dc.subject | Wellcome Trust | en |
| dc.subject.lcc | R1 | en |
| dc.title | HMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia | en |
| dc.type | Journal article | en |